Oct 26, 20262 min readMontréal’s DropGenie raises US$5 million to commercialize a gene-editing chipThe company says its chip can use up to 100 times fewer cells and less reagent than traditional tests; BetaKit’s report provides no independent comparison of those claimed savings.Read article